The Journal Acta Medica Bulgarica is the official scientific medical journal of the Medical University – Sofia. It has been published since 1973 year by the Central Medical Library, which is part of the university. The Medical University of Sofia is the oldest medical university in Bulgaria and achieved a good international ranking.
The journal Acta Medica Bulgarica accepts original research articles, clinical practice and scientific reviews and case reports in all areas of medicine. Some but not all of the areas covered by the journal are:health policy, oncology, public health, general and internal medicine, diabetes and endocrinology, cardiology, neurology, surgery, infectious diseases, emergency medicine, obesity and nutrition, pharmacology and many others.
Since first published online in 2014, the Journal Acta Medica Bulgarica has been subject of increasing interest. Our highly committed editorial board provided guidance on how to make the journal a trustful source of health-related research, turning it into a high-quality open access medical journal. The great team behind the journal - our associate editors, digital editor, and assistant editors, are also the people behind the progress of the journal and their work resulted in a continuous and steady increasing of the citation rates.
The peer review policy of the Journal Acta Medica Bulgarica is in fact a single-blinded peer review. After submitting a manuscript, it takes four to eight weeks until the review process is completed. The median peer review turnaround is 8-12 weeks. The rejection rate of the Journal is 50% for 2020 year. The time from receipt to acceptance for the majority of articles is 8-12 weeks. The time from acceptance to publication is from 4 weeks to 18 months. About 10-20% of the articles are rejected on submission, not reaching peer-review, due to major issues such as a poor English language or lack of compliance with the Journal’s Instructions to Authors.
The Journal is published quarterly and the four issues per year are printed at three-months intervals. Each month between 10 and 20 articles are submitted for evaluation, the approximate number of submitted papers for 2020 was 180 manuscripts, of which 70-80% original research articles; the remaining being case reports and review articles.
We hope that the journal will keep on improving its scientific quality, gaining international recognition among physicians and scientists from all medical fields in Bulgaria and around the world.
The email address for authors to submit their papers is email@example.com. To the attention of Dr. Mira Boyanova, MD.
Conflict of Interest Declaration and Author Agreement Form
It is the policy of the Journal Acta Medica Bulgarica to ensure objectivity and scientific rigor in the Journal. All authors are expected to disclose to the readers any conflict(s) of interest such as relationships with pharmaceutical companies, biomedical device manufacturers, etc.
Any potential conflict should be identified openly so that the readers may form their own judgements about the article with the full disclosure of the facts.
All Authors should have seen and approved the manuscript being submitted. The article should be the Authors' original work. The article should not be published elsewhere and should not be under consideration for publication elsewhere. On behalf of all Co-Authors, the corresponding Author shall bear full responsibility for the submission.
Polices on Animal & Human Rights
Acta Medica Bulgarica Journal has formulated policies to ensure protection and proper use of animals and human in all forms of research. Researchers should have a moral obligation towards the animals and human subjects they use for their research goals and they must treat them with compassion and consider their well-being while designing the projects.
All research articles that include human subjects should be performed in accordance to the World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects last edited October, 2013.
All research studies that use animal models should be performed in accordance with “the Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals’, Washington DC, National Academy Press.
All relevant information, including approval of the Local Ethics Committee, written informed consent information and ethical standards that the authors adhered to, should be clearly stated in the “Materials and Methods”section. The authors involved in research and experiments involving human subjects must confirm that informed consent was obtained from all participants and/or their legal guardians.
Peer Review Process
The PEER REVIEW politics of the Journal Acta Medica Bulgarica is a single-blind peer review.
After submitting a manuscript, the review process takes 6-8 weeks.
The median peer review turnaround is 8-12 weeks.
The time from acceptance of an article to its actual publication is from 4 weeks to 12-18 months.
The journal does not have article processing charges (APCs) nor article submission charges.
Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.
The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
Prof. Lachezar Traykov, MD, PhD, DSc, Academy Member of the Bulgarian Academy of Sciences, Rector of Medical University – Sofia, Bulgaria
Prof. Karolina Lubomirova, MD, PHD Vice Rector in Charge of Academic Affairs of Medical University – Sofia, Head of the Department of Occupational Medicine, Faculty of Public Health, Medical University – Sofia, Bulgaria
Assoc. Prof. Elitsa Deliverska, MD, PhD Vice Rector in Charge of Postgraduate Studies, Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Medical University – Sofia, Bulgaria
Prof. Tsvetalina Tankova, MD, PhD, DSc Vice Rector in Charge of International Integration and Project Funding, Head of the Department of Endocrinology, Faculty of Medicine, Medical University – Sofia, Bulgaria; Head of the Clinic of Diabetology, Clinical Centre of Endocrinology, University Hospital of Endocrinology "Acad. Ivan Penchev", Medical University – Sofia, Bulgaria
Prof. Valentina Petkova, MPharm, PhD, DSc Vice Rector in Charge of Science and Accreditation, Department of Social Pharmacy, Faculty of Pharmacy, Medical University – Sofia, Bulgaria
Prof. Mihail Boyanov, MD, PhD, DSc, Department Internal Medicine, Faculty of Medicine, Medical University – Sofia, Bulgaria,Clinic of Endocrinology and Metabolism, University Hospital “Alexandrovska”, Sofia, Bulgaria
Prof. Dimitar Bulanov, MD, PhD Dean of Medical Faculty, Department of General and Hepato-Pancreatic Surgery, Medical University – Sofia, Bulgaria; Clinic of General and Hepato-Pancreatic Surgery, University Hospital “Alexandrovska”, Sofia, Bulgaria
Faculty of Dental Medicine
Prof. Bozhidar Yordanov, DMD, PhD Dean of Faculty of Dental Medicine, Head of the Department of Prosthetic Dental Medicine, Faculty of Dental Medicine, Medical University – Sofia, Bulgaria
Faculty of Pharmacy
Prof. Alexander Zlatkov, MPharm, PhD, DSc Dean of Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University – Sofia, Bulgaria
Faculty of Public Health “Prof. Tzecomir Vodenitcharov, MD, DSc
Prof. Magdalena Aleksandrova, PhD Dean of Faculty of Public Health “Prof. Tzecomir Vodenitcharov, MD, DSc",Medical University – Sofia, Bulgaria
Medical College “Yordanka Filaretova” – Sofia
Prof. Zaharinka Savova, MD, PhD Director of the Medical College “Yordanka Filaretova” – Sofia, Bulgaria
Branch “Prof. Dr. Ivan Mitev”
Prof. Pavlinka Dobrilova, PhD Director of the Branch “Prof. Dr. Ivan Mitev”, Vratsa, Medical University – Sofia, Bulgaria
Mira Boyanova, MD, Proofreader at the Scientific Medical Information Section, Central Medical Library, Medical University - Sofia
Mira Boyanova, Proofreader at the Scientific Medical Information Section, Central Medical Library, Medical University - Sofia
Central Medical Library, Medical University - Sofia, Bulgaria
De Gruyter Poland
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15
Acta Medica Bulgarica is covered by the following services:
- Baidu Scholar
- CABI (over 50 subsections)
- CNKI Scholar (China National Knowledge Infrastructure)
- CNPIEC - cnpLINKer
- DOAJ (Directory of Open Access Journals)
- EBSCO (relevant databases)
- EBSCO Discovery Service
- Genamics JournalSeek
- Google Scholar
- Japan Science and Technology Agency (JST)
- KESLI-NDSL (Korean National Discovery for Science Leaders)
- Microsoft Academic
- Naver Academic
- Naviga (Softweco)
- Primo Central (ExLibris)
- ProQuest (relevant databases)
- QOAM (Quality Open Access Market)
- Semantic Scholar
- Summon (ProQuest)
- Text Mining
- Ulrich's Periodicals Directory/ulrichsweb
- WanFang Data
- WorldCat (OCLC)
The email address for authors to submit papers is firstname.lastname@example.org - Mira Boyanova, MD.
Acta Medica Bulgarica Journal official website is available at: http://cml.mu-sofia.bg/CML/page134.html
All articles published in our journal are open access and freely available online, immediately upon publication. The Journal doesn’t charge publication fees. The Journal does not have an article processing charge (APC).
The Review Process
Following receipt of a new manuscript, the manuscript will be assigned to an Editorial board who will be responsible for managing the peer review process. Each manuscript will be reviewed by one reviewer who is highly competent and recognized in the particular field of the submitted manuscript. Typically, a 2-week deadline is given to complete the review. After receipt of the reviews, a decision is made to either accept, give the authors an opportunity to revise or to reject the manuscript. Revised manuscripts are typically re-evaluated by the same reviewers. Depending upon this evaluation, the manuscript may be accepted or rejected.
Grounds for Declining a Manuscript
A manuscript may be declined if the study was judged as too preliminary in nature or was in an inappropriate scientific area. Manuscripts may be rejected if the findings are not sufficiently novel or do not contain enough new information.
The journals publish original research and review material. Material previously published in whole or in part shall not be considered for publication.
An author should have participated in either the conception or planning of the work, the interpretation of the results and the writing of the paper. An acknowledgment accompanying the paper is appropriate recognition for others who have contributed to a lesser extent. The signature of each author on the Affirmation of Originality and Copyright Release form that must be submitted with the manuscript indicates that all authors have had a part in the writing and final editing of the report and all are prepared to take public responsibility for the work, sharing responsibility and accountability for the results. Potential conflicts of interest should be described when submitting manuscripts.
The obligation of an author is to present a clear, honest, accurate, and complete account of the research performed. Each manuscript should describe a complete study or a completed phase of an extended study.
Conflict of Interest
Special care is taken to assure that the authors' views are balanced and unencumbered, and that the Acta Medica Bulgarica policies on disclosure of conflicts of interest are implemented.
Obligations of Reviewers
The reviewer should strive to provide accurate, detailed, and constructive criticisms, and the review should be supported by appropriate references, especially if unfavorable. The reviewer should also note whether the work of others is properly cited.
Obligations of Editors
The Editorial board directs and supervises the policies of a journal and is responsible for maintaining its scientific and literary quality. The first obligation of the Editorial board is to make certain that all authors receive confidential, expert, critical, and unbiased reviews of their work in a timely fashion.
The editors reserve the right to reject manuscripts describing research that does not meet acceptable standards of research behavior as determined by the Geneva Convention or the Declaration of Helsinki.
Unethical acts include, but are not limited to, plagiarism, fabrication, falsification, redundant or duplicate publication, violation of federal, state or institutional rules, and honorary authorship.
Advertising in the journal is not allowed.
Open Access Statement
The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users.